Inhibikase Therapeutics, Inc. - Common Stock (IKT)

2.2650
+0.0550 (2.49%)
NASDAQ· Last Trade: Jul 30th, 12:36 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors